Moderna, Inc. vs ABRDN Physical Gold Shares ETF — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while ABRDN Physical Gold Shares ETF trades at $38.89. The key difference: Moderna, Inc. is trading nearer its 52-week high, ABRDN Physical Gold Shares ETF nearer its low. Which is the better fit depends on your goals.
| MRNA | SGOL | |
|---|---|---|
Market Cap | $23.60B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $81.80 | $51.41 |
52-Week Low | $22.36 | $31.18 |
Enterprise Value | $19.70B | — |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →